October 22, 2019

After years of hype, digital technologies are making a mark on healthcare and life sciences. Devices with health-minded features, such as home-monitoring systems and smart watches, are helping patients and doctors monitor daily health. Prescription mobile apps to treat substance use disorders have been cleared by the FDA and are rolling out. Machine learning and A.I. tools are enhancing treatment plans, augmenting clinicians’ skills in tasks such as reading medical scans and diagnosing disease, and improving drug discovery. But the proliferation of digital health products presents trade-offs for consumers and care providers around data privacy, security, and ownership. The sector’s evolution also raises plenty of other questions about clinical integration, workflows, business models, and the future of healthcare jobs.

8:30 – 9:30am

Registration, Breakfast & Networking

9:30 – 9:40am

Welcome & Opening Remarks

Greg Huang – Editor in Chief, Xconomy

9:40 – 10:10am

Translating Research Into Real Products

Rosalind Picard – Professor, MIT Media Lab; Co-founder, Empatica & Affectiva

Through her companies, Picard has twice transformed data research into health products (computer systems that sense human emotions; a wristband device that alerts caregivers of seizures).

10:10 – 10:40am

Building a Market for Digital Therapeutics

Eddie Martucci – Co-founder & CEO, Akili Interactive Labs
Corey McCann – CEO, Pear Therapeutics
Kevin McRaith – CEO, Welldoc
Ana Maiques – CEO, Neuroelectrics (moderator)

How can digital therapeutics companies win over doctors used to prescribing chemical-based treatments?

10:40 – 11:05am

Case Study: Telehealth’s Progress

Danielle Russella –  General Manager of Payer Solutions, American Well
Greg LeGrow – Senior Director of Consumer and Provider Solutions, Blue Cross Blue Shield of Massachusetts

A look at how the growing use of telehealth tools is playing out for patients and doctors in Massachusetts.

11:05 – 11:10am

Burst Talk: AI in Telehealth

Liz Asai – Co-founder & CEO, 3Derm

Telemedicine startup 3Derm is using AI in tasks such as assessing medical image quality, but it has grander ambitions for the technology: potentially using AI to detect skin cancer.

11:10 – 11:40am

Networking Break

11:40am – 12:05pm

Harnessing Patient Data for Better Care

Anmol Madan – Chief Data Scientist, Livongo Health
Brian Dowling – Senior Editor, Xconomy (moderator)

Livongo Health sells devices and software to track and manage pre-diabetes, diabetes, and high blood pressure—and just went public along with a handful of other healthtech companies. 

12:05 – 12:40pm

The Coach in Your Pocket

Eric Gastfriend – CEO, DynamiCare Health
Cheryl Morrison Deutsch – Chief Experience Officer, Zillion
Reena Pande – Chief Medical Officer, Ableto
Patricia Forts – Deputy Chief of Innovation and Strategy, Harvard Pilgrim Health Care (moderator)

Digital tools are nudging users to make better health decisions, such as maintaining sobriety or choosing meals and workouts. 

12:40 – 1:50pm

Lunch & Gallery Tours

1:50 – 2:15pm

How Reimbursement Changes are Changing the Game

Pete Sally – Managing Partner, Seae Ventures
Jessica Zeaske – Partner, Echo Health Ventures
Jody Rose – President, New England Venture Capital Association (moderator)

The fee-for-service healthcare system and complex system of private and public payers can make getting paid for new technology approaches a challenge.

2:15 – 2:50pm

Future of Digital Health: The App Ecosystem

John Halamka – Executive Director, Beth Israel Lahey Health; Professor of Medicine, Harvard
Jeff Bauter Engel – Tech Deputy Editor, Xconomy (moderator)

John Halamka has long been on the front lines of deploying new technology in a hospital, and will offer a keen view of what lies ahead for digital tools in care settings.

2:50 – 3:30pm

AI Frontiers in the Clinic & Pharma

Spring Behrouz – CEO, NeuroInitiative
Kenneth Harper – VP & GM of Healthcare Virtual Assistants, Nuance Communications
Andrew Le – CEO, Buoy Health
Brian Scogland – Associate Principal Consultant, Halloran Consulting Group (moderator)

Machine learning and artificial intelligence tools are enhancing treatment plans, improving drug discovery, and augmenting clinicians’ skills in tasks such as reading medical scans and diagnosing disease. 

3:30 – 4:30pm

Networking Reception

Schedule is subject to change.